Weighing Risks and Benefits of Liraglutide — The FDA’s Review of a New Antidiabetic Therapy

Posted on by Angela Paisley

http://content.nejm.org/cgi/content/full/NEJMp1001578?query=TOC

FDA’s summary with regards to approval of liraglutide. Discussion of the potential benefits of improved glycaemic control whilst highlighting potentially serious safety concerns.

Published by Angela Paisley

Leave a Reply

Fill in your details below or click an icon to log in:

Gravatar
WordPress.com Logo

You are commenting using your WordPress.com account. ( Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. ( Log Out /  Change )

Cancel

Connecting to %s